Synthesis and in-vitro antibacterial activity of 5-substituted 1-methyl-4-nitro-1H-imidazoles. 2008

Bahram Letafat, and Saeed Emami, and Alireza Aliabadi, and Negar Mohammadhosseini, and Mohammad Hassan Moshafi, and Ali Asadipour, and Abbas Shafiee, and Alireza Foroumadi
Department of Chemistry and Islamshar Young Researchers Club, Islamic Azad University, Islamshahr-Branch, Tehran, Iran.

A series of 5-substituted 1-methyl-4-nitro-1H-imidazole derivatives were synthesized and evaluated for in-vitro antibacterial activity against a panel of microorganisms including Staphylococcus aureus, Staphylococcus epidermidis, Bacillus subtilis, Escherichia coli, Klebsiella pneumonia, Enterobacter aerogenes, and Helicobacter pylori using conventional agar dilution method. Among the test compounds, 1-methyl-4-nitro-5-(phenylsulfonyl)-1H-imidazole was the most potent against Gram-positive bacteria, with a MIC value of < or =8 microg/mL. All compounds showed no significant activity against Gram-negative bacteria at concentrations < or =64 microg/mL. The MIC values against 15 clinical isolates of H. pylori indicated that compounds 10 and 11 were the most active compounds in this series in terms of inhibiting the growth of H. pylori (MIC = 2 microg/mL). It was also demonstrated that their corresponding activities were four times larger than that of metronidazole.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009593 Nitroimidazoles IMIDAZOLES having a nitro moiety. Nitroimidazole
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015169 Colony Count, Microbial Enumeration by direct count of viable, isolated bacterial, archaeal, or fungal CELLS or SPORES capable of growth on solid CULTURE MEDIA. The method is used routinely by environmental microbiologists for quantifying organisms in AIR; FOOD; and WATER; by clinicians for measuring patients' microbial load; and in antimicrobial drug testing. Agar Dilution Count,Colony-Forming Units Assay, Microbial,Fungal Count,Pour Plate Count,Spore Count,Spread Plate Count,Streak Plate Count,Colony Forming Units Assay, Microbial,Colony Forming Units Assays, Microbial,Agar Dilution Counts,Colony Counts, Microbial,Count, Agar Dilution,Count, Fungal,Count, Microbial Colony,Count, Pour Plate,Count, Spore,Count, Spread Plate,Count, Streak Plate,Counts, Agar Dilution,Counts, Fungal,Counts, Microbial Colony,Counts, Pour Plate,Counts, Spore,Counts, Spread Plate,Counts, Streak Plate,Dilution Count, Agar,Dilution Counts, Agar,Fungal Counts,Microbial Colony Count,Microbial Colony Counts,Pour Plate Counts,Spore Counts,Spread Plate Counts,Streak Plate Counts

Related Publications

Bahram Letafat, and Saeed Emami, and Alireza Aliabadi, and Negar Mohammadhosseini, and Mohammad Hassan Moshafi, and Ali Asadipour, and Abbas Shafiee, and Alireza Foroumadi
August 2007, Acta crystallographica. Section C, Crystal structure communications,
Bahram Letafat, and Saeed Emami, and Alireza Aliabadi, and Negar Mohammadhosseini, and Mohammad Hassan Moshafi, and Ali Asadipour, and Abbas Shafiee, and Alireza Foroumadi
July 2009, European journal of medicinal chemistry,
Bahram Letafat, and Saeed Emami, and Alireza Aliabadi, and Negar Mohammadhosseini, and Mohammad Hassan Moshafi, and Ali Asadipour, and Abbas Shafiee, and Alireza Foroumadi
December 2005, European journal of medicinal chemistry,
Bahram Letafat, and Saeed Emami, and Alireza Aliabadi, and Negar Mohammadhosseini, and Mohammad Hassan Moshafi, and Ali Asadipour, and Abbas Shafiee, and Alireza Foroumadi
August 2009, European journal of medicinal chemistry,
Bahram Letafat, and Saeed Emami, and Alireza Aliabadi, and Negar Mohammadhosseini, and Mohammad Hassan Moshafi, and Ali Asadipour, and Abbas Shafiee, and Alireza Foroumadi
November 2009, European journal of medicinal chemistry,
Bahram Letafat, and Saeed Emami, and Alireza Aliabadi, and Negar Mohammadhosseini, and Mohammad Hassan Moshafi, and Ali Asadipour, and Abbas Shafiee, and Alireza Foroumadi
July 1978, Journal of pharmaceutical sciences,
Bahram Letafat, and Saeed Emami, and Alireza Aliabadi, and Negar Mohammadhosseini, and Mohammad Hassan Moshafi, and Ali Asadipour, and Abbas Shafiee, and Alireza Foroumadi
August 2005, Acta crystallographica. Section C, Crystal structure communications,
Bahram Letafat, and Saeed Emami, and Alireza Aliabadi, and Negar Mohammadhosseini, and Mohammad Hassan Moshafi, and Ali Asadipour, and Abbas Shafiee, and Alireza Foroumadi
November 1981, Journal of medicinal chemistry,
Bahram Letafat, and Saeed Emami, and Alireza Aliabadi, and Negar Mohammadhosseini, and Mohammad Hassan Moshafi, and Ali Asadipour, and Abbas Shafiee, and Alireza Foroumadi
November 2011, Acta crystallographica. Section E, Structure reports online,
Bahram Letafat, and Saeed Emami, and Alireza Aliabadi, and Negar Mohammadhosseini, and Mohammad Hassan Moshafi, and Ali Asadipour, and Abbas Shafiee, and Alireza Foroumadi
December 2015, Molecules (Basel, Switzerland),
Copied contents to your clipboard!